Induction of lymphocyte apoptosis and prolongation of allograft survival by FTY720.
Suzuki
S
S
Department of Experimental Surgery and Bioengineering, National Children's Medical Research Center, Tokyo, Japan.
Li
X K
XK
Shinomiya
T
T
Enosawa
S
S
Kakefuda
T
T
Mitsusada
M
M
Amemiya
H
H
Takahara
S
S
Amari
M
M
Naoe
S
S
Hoshino
Y
Y
Chiba
K
K
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D002460:Cell Line; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000494:pharmacology; D004285:Dogs; D000068876:Fingolimod Hydrochloride; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000633:toxicity; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008223:Lymphoma; D008297:Male; D051379:Mice; D008817:Mice, Mutant Strains; D009368:Neoplasm Transplantation; D011409:Propylene Glycols / Q000494:pharmacology* / Q000633:toxicity; D013110:Sphingosine / Q000031:analogs & derivatives; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology; D014407:Tumor Cells, Cultured
D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D016572:Cyclosporine; D003404:Creatinine; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine